These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8249053)

  • 1. Enzyme immunoassays for a new angiotensin-converting enzyme inhibitor, zabicipril, and its active metabolite in human plasma: application to pharmacokinetic studies.
    Ezan E; Morge X; Lelièvre E; Créminon C; Piraube C; Grognet JM
    Ther Drug Monit; 1993 Oct; 15(5):448-54. PubMed ID: 8249053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoassays for a new angiotensin-converting enzyme inhibitor, zabicipril, and its active metabolite, zabiciprilat, in human plasma.
    Lelievre E; Cardona H; Brillanceau MH; Piraube C; Sauveur C
    J Pharm Sci; 1992 Nov; 81(11):1065-70. PubMed ID: 1447705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic, pharmacokinetic and humoral effects of oral zabicipril, an angiotensin converting enzyme inhibitor in normotensive man.
    MacDonald NJ; Hughes DM; Lees KR; Reid JL
    Br J Clin Pharmacol; 1990 Jul; 30(1):107-13. PubMed ID: 2202384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic-pharmacodynamic model relating zabiciprilat plasma concentrations to brachial and femoral haemodynamic effects in normotensive volunteers.
    Bellissant E; Giudicelli JF
    Br J Clin Pharmacol; 1998 Oct; 46(4):383-93. PubMed ID: 9803988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic and renal haemodynamic effects of angiotensin converting enzyme inhibition by zabicipril in young and in old normal men.
    Naeije R; Fiasse A; Carlier E; Opsomer M; Leeman M
    Eur J Clin Pharmacol; 1993; 44(1):35-9. PubMed ID: 8436152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and regional hemodynamic effects of zabicipril in healthy volunteers.
    Bellissant E; Thuillez C; Pussard E; Giudicelli JF
    Clin Pharmacol Ther; 1992 Mar; 51(3):308-19. PubMed ID: 1531952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac and vascular effects of chronic angiotensin converting enzyme inhibition at subantihypertensive doses.
    Gohlke P; Stoll M; Lamberty V; Mattfeld T; Mall G; van Even P; Martorana P; Unger T
    J Hypertens Suppl; 1992 Aug; 10(6):S141-4. PubMed ID: 1432317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A radioimmunoassay for the angiotensin converting enzyme inhibitor ramipril and its active metabolite.
    Eckert HG; Münscher G; Oekonomopulos R; Strecker H; Urbach H; Wissmann H
    Arzneimittelforschung; 1985; 35(8):1251-6. PubMed ID: 3000393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of angiotensin-converting enzyme inhibition on intimal thickening in rabbit collared carotid artery.
    De Meyer GR; Bult H; Kockx MM; Herman AG
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):614-20. PubMed ID: 8569224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibition increases collateral-dependent muscle blood flow.
    Yang HT; Terjung RL
    J Appl Physiol (1985); 1993 Jul; 75(1):452-7. PubMed ID: 8397181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new radioimmunoassay for the determination of the angiotensin-converting enzyme inhibitor perindopril and its active metabolite in plasma and urine: advantages of a lysine derivative as immunogen to improve the assay specificity.
    van den Berg H; Resplandy G; de Bie AT; Floor W; Bertrand M; Arts CJ
    J Pharm Biomed Anal; 1991; 9(7):517-24. PubMed ID: 1817672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination in plasma of angiotensin-converting enzyme inhibitor by inhibitor-binding assay.
    Shioya H; Shimojo M; Kawahara Y
    J Chromatogr; 1991 Aug; 568(2):309-14. PubMed ID: 1783636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay for imidapril, a new angiotensin-converting enzyme inhibitor, and imidaprilat, its active metabolite, in human plasma and urine.
    Yamanaka K; Morikawa S; Murata K; Banno K; Sato T; Takai T; Suzuki T; Mizobe M; Ito M; Ishibashi K
    J Pharm Biomed Anal; 1996 Jan; 14(3):281-7. PubMed ID: 8851752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved analytical procedure for the measurement of captopril in human plasma by gas chromatography--mass spectrometry and its application to pharmacokinetic studies.
    Franklin ME; Addison RS; Baker PV; Hooper WD
    J Chromatogr B Biomed Sci Appl; 1998 Jan; 705(1):47-54. PubMed ID: 9498669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First LC-MS/MS electrospray ionization validated method for the quantification of perindopril and its metabolite perindoprilat in human plasma and its application to bioequivalence study.
    Jain DS; Subbaiah G; Sanyal M; Pande UC; Shrivastav P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 837(1-2):92-100. PubMed ID: 16709467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapid and sensitive liquid chromatography-tandem mass spectrometric assay for moexipril, an angiotensin-converting enzyme inhibitor in human plasma.
    Karra VK; Mullangi R; Pilli NR; Inamadugu JK; Ravi VB; Seshagiri Rao JV
    Biomed Chromatogr; 2012 Dec; 26(12):1552-8. PubMed ID: 22419504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibition increases exercise tolerance and muscle blood flow in rats with peripheral arterial insufficiency.
    Yang HT; Terjung RL
    J Clin Pharmacol; 1994 Apr; 34(4):345-55. PubMed ID: 8006202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme immunoassay discrimination of a new angiotensin-converting enzyme (ACE) inhibitor, cilazapril, and its active metabolite.
    Tanaka H; Yoneyama Y; Sugawara M; Umeda I; Ohta Y
    J Pharm Sci; 1987 Mar; 76(3):224-7. PubMed ID: 3035170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of captopril in human blood by an enzyme-linked immunosorbent assay.
    Jehanli AM; Arafat T; al-Shami M
    J Pharm Pharmacol; 1996 Sep; 48(9):914-7. PubMed ID: 8910853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioanalysis of captopril: two sensitive high-performance liquid chromatographic methods with pre- or postcolumn fluorescent labeling.
    Kok RJ; Visser J; Moolenaar F; de Zeeuw D; Meijer DK
    J Chromatogr B Biomed Sci Appl; 1997 May; 693(1):181-9. PubMed ID: 9200533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.